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Abstract
Background: In analogy to normal stem cell differentiation, the current cancer stem cell (CSC) model presumes a
hierarchical organization and an irreversible differentiation in tumor tissue. Accordingly, CSCs should comprise only a small
subset of the tumor cells, which feeds tumor growth. However, some recent findings raised doubts on the general
applicability of the CSC model and asked for its refinement.
Methodology/Principal Findings: In this study we analyzed the CSC properties of mammary carcinoma cells derived from
transgenic (WAP-T) mice. We established a highly tumorigenic WAP-T cell line (G-2 cells) that displays stem-like traits. G-2
cells, as well as their clonal derivates, are closely related to primary tumors regarding histology and gene expression profiles,
and reflect heterogeneity regarding their differentiation states. G-2 cultures comprise cell populations in distinct
differentiation states identified by co-expression of cytoskeletal proteins (cytokeratins and vimentin), a combination of cell
surface markers and a set of transcription factors. Cellular subsets sorted according to expression of CD24a, CD49f, CD61,
Epcam, Sca1, and Thy1 cell surface proteins, or metabolic markers (e.g. ALDH activity) are competent to reconstitute the
initial cellular composition. Repopulation efficiency greatly varies between individual subsets and is influenced by
interactions with the respective complementary G-2 cellular subset. The balance between differentiation states is regulated
in part by the transcription factor Sox10, as depletion of Sox10 led to up-regulation of Twist2 and increased the proportion
of Thy1-expressing cells representing cells in a self-renewable, reversible, quasi-mesenchymal differentiation state.
Conclusions/Significance: G-2 cells constitute a self-reproducing cancer cell system, maintained by bi- and unidirectional
conversion of complementary cellular subsets. Our work contributes to the current controversial discussion on the existence
and nature of CSC and provides a basis for the incorporation of alternative hypotheses into the CSC model.
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Introduction
The definition by Rollin Hotchkiss of living matter ‘‘as the
repetitive production of ordered heterogeneity’’ is applicable to
normal as well as to tumor tissue [1]. The cellular heterogeneity
observed in many solid tumors at the functional and structural
level is reminiscent to the complex cellular organization of the
respective normal tissues. This similarity of tumor to normal tissue
legitimizes the formal application of principles and concepts in
developmental biology to cancer research. The model of cancer
stem cells (CSCs) [2,3] describes a tumor as a hierarchically
organized system of stem-like cells and their differentiated
progeny. As postulated by the CSC model, a small subset of cells
drives tumor growth and is responsible for tumor relapse after an
apparently successful therapy. These tumor cells, referred to as
CSCs, tumor-initiating or tumorigenic cells, are distinguished by a
combination of operationally defined common or unique cell
surface associated markers and the ability to establish the disease
in appropriate recipient mice [4]. In contrast to the stochastic
model of clonal evolution, which ascribes tumor cell heterogeneity
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12103to genetic differences in the tumor cell pool [5], the CSC model
postulates that epigenetic rather than genetic differences distin-
guish tumorigenic from non-tumorigenic cells, thereby providing a
basis for the hierarchical relationships within the tumor cell
population [6].
Recent findings that tumorigenic cells can comprise a significant
fraction of the tumor mass [7] question the strictly hierarchical
organization of the tumor tissue [8], and rather argue for
‘‘phenotypic plasticity’’ of tumor cells [9], maintained by
homeostatic mechanisms [10]. Hence, CSCs do not exist as a
unique population defined by discrete molecular properties, but
rather together with their differentiated progeny constitute a self-
reproducing ‘‘stem cell system’’ where the cellular composition is
regulated by interconversion of various differentiation states [9].
Tumors of epithelial origin (carcinomas) usually display high
histological heterogeneity reflecting various differentiation states of
individual cells. Based on three phenotypic criteria - cell
polarization, cell cohesiveness and expression pattern of cytoplas-
mic intermediate filament (cIF) proteins - it has been suggested to
define four phenotypes, ranging from purely epithelial to entirely
mesenchymal [11]. Accordingly, the differentiation state of
individual cells in carcinomas corresponds to an epithelial, a
mesenchymal and an intermediate phenotype. These differentia-
tion states can be further subdivided into stable and transitory
subtypes, which altogether are assembled into a dynamic
‘‘ecosystem’’. The process termed epithelial-mesenchymal transi-
tion (EMT) and its counterpart, termed mesenchymal-epithelial
transition (MET) [12,13], describe the conversion of opposite
differentiation states. These transitions have been recently linked
to cell stemness by the observation that induction of EMT in
human breast epithelial cell culture models creates a subset of cells
highly enriched in CSCs [14,15]. The model emerging from these
studies proposes that in carcinomas EMT and MET account for
the generation of a subset of cells which are in balance with the
tumor epithelial compartment and are able to regenerate the
whole tumor cell population [9].
Transgenic and knockout mice provide syngeneic (or congenic)
models for CSC research, as they allow to establish cancer diseases
in immune-competent animals that mimic the corresponding
human situation, and are a source for cell lines enabling studies of
CSC properties. However, the suitability of mouse models is often
restrictedby the fact that the effects of expression of an oncogene, or
loss of a tumor suppressor, are exerted already at the embryonic
stage and during tissue development, while in the vast majority of
human cancers genetic alterations leading to cancer will occur in
cells of adult tissues. WAP-T transgenic mice [16–19] have proven
to be a usefulmodel forthe analysis of oncogene-induced mammary
carcinogenesis in adult mice. In female WAP-T mice activation of
the transgene, the simian virus 40 (SV40) early gene region flanked
by an ,1.4 kb upstream region of the gene coding for the mouse
wheyacidicprotein(WAP)[20],isinitiatedduringlatepregnancyin
mammary epithelial (ME) cells concordant with the endogenous
Wap gene [21]. Expression of SV40 early genes coding for large T-
antigen(LT)andsmallt-antigen(st)drivesmammarycarcinogenesis
by mimicking a variety of genetic alterations commonly seen in
human breast carcinomas, like abrogation of the pRB-controlled
G1-checkpoint [22], and inactivation of the tumor suppressor p53
[23]. As a consequence of SV40 early gene expression, parous
WAP-T mice develop multiple alveolar lesions – multifocal
intraepithelial neoplasia (MIN). Some of these focal lesions further
progress to invasive, but rarely metastatic mammary carcinomas
[19]. Morphologically, the tumors developing in WAP-T mice are
adenocarcinomas, ranging from a well to a poorly differentiated
phenotype [16]. The relevance of this model is emphasized by the
close similarity in histology of the mouse tumors with corresponding
human tumors [19].
In this study we asked whether WAP-T tumors are better
described by the classical CSC model or by alternative hypotheses.
We found that tumorigenic cells are relatively frequent in WAP-T
tumors (up to 1/10) and are able to recapitulate the phenotype of
theirrespective primarytumorsafterorthotopictransplantationinto
syngeneic mice. To study their tumorigenic properties in more
detail,we established from a WAP-T tumor a cell line (G-2 cells). G-
2 cells with high efficiency form tumors in syngeneic mice which by
gene expression and phenotypic analyses are closely related to
primary tumors. G-2 cell cultures are characterized by a basal/
luminal gene expression signature, heterogeneity of differentiation
states and the presence of complementary cellular subsets that can
be separated according to differences in expression of certain
stemness-related cell surface markers. We show that stringently
FACS-separated subsets of G-2 cells are competent to reconstitute
the initial cellular composition of the cell culture when individually
cultured. Our data argue for a self-reproducing homeostatic
‘‘cancer cell system’’, where the balance relies on interconversion
of the complementary cellular subsets, their interactions and
transcriptional competence. In support of the EMT-CSC model
[9], we identified in the G-2 culture a self-renewing population of
cells characterized by expression of Thy1 and displaying spontane-
ous reversibility of a quasi-mesenchymal differentiation state.
Results
WAP-T tumors contain a high proportion of tumorigenic
cells
A decisive criterion for CSCs is their ability to initiate tumor
growth after transplantation into appropriate recipient mice and
to recapitulate the phenotype of the original tumor. Orthotopic
transplantation of serially diluted WAP-T tumor cells revealed
that as low as 10
2 cells from well to moderately differentiat-
ed (low-grade) tumors, and as low as 10
1 cells from poorly
differentiated (high-grade) tumors were able to induce mammary
carcinomas in syngeneic mice (Figure 1A). Transplanted tumors
usually reflected the phenotype of the parental tumors
(Figure 1B). However, transplantation of cells from a low-grade
tumor sometimes also gave rise to high-grade tumors. As pauci-
clonality of WAP-T tumors has been occasionally observed [17],
the outgrowth of cells from a high-grade tumor cell pool cannot
be excluded.
Characterization of G-2 cells and their clonal derivatives
To avoid the complications associated with the analysis of
primary tumor cells, we established a cell line from a WAP-T
tumor (G-2 cells) that would allow analysis of mammary tumor
initiating and stem cell properties under in vitro and in vivo settings
(see MATERIALS AND METHODS for details).
a) In vitro. Starting from the first passages G-2 cell cultures
exhibited an inhomogeneous growth pattern, featured by tightly
packed colonies embedded into cobblestone-like areas (Figure 2A).
In subsequent passages G-2 cells preserved the ability to form
multiple cell clusters and three-dimensionally expanding colonies,
but acquired a more fibroblastic-like morphology (Figure 2B, C).
G-2 cells exhibit stable, though heterogeneous expression of SV40-
LT, which in complex with the endogenous wild-type p53
accumulated in the nuclei of the majority of cells (Figure 2D),
thereby reflecting SV40-LT expression in vivo. Expression of SV40-
LT correlates with endogenous Wap gene activity (Figure 2E),
indicating that regulators responsible for transcription of the Wap
gene are constitutively active in G-2 cells. In support, lentiviral
WAP-T Cancer Cell System
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control of a ,1.4 kb Wap promoter fragment showed that even
after 2 weeks in culture a large population of the FACS-enriched
eGFP
+-cells remained eGFP-positive (Figure 2F). These cells
occasionally formed dense foci of highly eGFP expressing cells.
Since constitutive Wap gene activity has been linked to
committed bipotent alveolar progenitors and CD61
+ luminal-
restricted progenitors, which are presumptive targets of oncogene
activity [24], we performed a cell lineage analysis by immunoflu-
orescence (IF) staining for the luminal epithelial cell marker keratin
18 (Krt18), the basal/myoepithelial cell markers keratin 5 (Krt5)
and keratin 14 (Krt14). In early passages the majority of the G-2
cells expressed both Krt14 (Figure 2G) and Krt18 intermediate
filament proteins (Figure 2H); however the usual co-polymeriza-
tion partner of Krt14, the Krt5 protein, was not detectable by a
specific antibody (data not shown). In subsequent passages slight
variations in the individual expression levels of Krt14 and Krt18
(data not shown) and a significant fluctuation in the number of
cytokeratin-expressing cells ranging from 40 to 70% were
observed. Figure 2I shows as an example the FACS-based
quantitation of Krt18 expression in G-2 cells at passage 20,
indicating transition towards a mesenchymal differentiation state.
Therefore, expression of the intermediate filament protein
vimentin was analyzed as a widely-used marker of mesenchymal
cells and carcinoma cells undergoing transition between epithelial
and mesenchymal differentiation states [25,26]. Independent of
passage number nearly all G-2 cells express vimentin, whereby the
intensity of vimentin expression ranges from a diffuse cytoplasmic
distribution and faint filamentous structures to an abundant
filamentous network (Figure 2J–K show vimentin/SV40-LT and
vimentin/Krt18 co-staining at passage 10). Figure 2L shows as an
example the FACS-based quantitation of vimentin expression in
G-2 cells at passage 20. SV40-LT expression was detected almost
always also in cells strongly expressing vimentin (Figure 2J).
Figure 1. Tumorigenic property of WAP-T tumor cells. (A) Cells from high-grade WAP-T tumors are more tumorigenic than cells from low-grade
tumors. Serially diluted (10
1,1 0
2,1 0
3,1 0
4) freshly isolated WAP-T tumor cells were injected into the left abdominal mammary gland as described in
MATERIALS AND METHODS.( B) H&E staining of low-grade and high-grade, respectively, WAP-T primary and their corresponding transplanted tumor. The
transplanted tumors grew after injection of 10
4 or 10
2 cells, respectively, from low-grade and high-grade tumors. Scale bar: 100 mm.
doi:10.1371/journal.pone.0012103.g001
WAP-T Cancer Cell System
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cultures (Figure 2J, labeled by arrows). In summary, by
immunostaining analysis we observed firstly that the majority of
G-2 cells are distinguished by a differentiation state characterized
by co-expression of vimentin and cytokeratins, secondly that the
number of cells devoid of cytokeratins fluctuates between passages,
and thirdly that a minor population of cells expressing cytokeratins
but totally lacking vimentin is always present.
Such heterogeneity in differentiation states may reflect a
multiclonal origin of the G-2 cell culture, as this culture was
derived from a whole tumor. To address this possibility, G-2 cells
were cloned in soft agar, and ten colonies were expanded into
stable cell lines. As visualized by IF-staining, the G-2 cell pattern of
cytokeratin expression was reproduced in G-2 cell derived clones
(Figure S1A–B; shown as example for clones G-2C9 and G-2C11),
although according to qPCR analysis the relative levels of Krt14
Figure 2. Characterization of G-2 cells in cell culture. (A–C) Phase-contrast images of G-2 cells in an early (p9) and a later (p29) passage. (D)
Confocal image of G-2 cells stained with anti-SV40-LT (green) and anti-p53 (red) antibodies. Images were merged with a differential interference
contrast (DIC) micrograph. (E) Confocal image of G-2 cells stained with anti-Wap (green) antibody. Nuclei were visualized by DRAQ5 staining (blue).
(F) Live-cell fluorescence image of G-2 cells after lentiviral transduction with an eGFP reporter construct under control of the Wap-promoter. FACS-
enriched eGFP
+-cells were kept in culture for 2 weeks. (G and H) Keratin 14 (red) and keratin 18 (green) immunostaining of cultured G-2 cells. Nuclei
were visualized by DAPI staining (blue). (I) FACS-based quantitation of keratin 18 expression in G-2 cells at passage 20. (J and K) Vimentin (green) and
SV40-LT (red)/keratin 18 (red) co-staining of cultured G-2 cells at passage 10. Arrows mark G-2 cells without detectable SV40-LT expression. Nuclei
were visualized by DAPI staining (blue). (L) FACS-based quantitation of vimentin expression in G-2 cells at passage 20. Scale bars: A: 150 mm; B and C:
200mm; D and E:2 0mm; F, G, H and J: 100 mm; K:5 0 mm.
doi:10.1371/journal.pone.0012103.g002
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S1C–D). Also in the secondary clones, derived by agar cloning
from G-2C9 and G-2C11 clones, a 2–3 fold variation in the
transcription of Krt14 and Krt18 genes could be demonstrated
(Figure S1E–F). Similar to the parental culture, heterogeneous
expression of vimentin was observed in G-2 cell clones (Figure
S1G). Therefore, we conclude that the presence of cell populations
in epithelial, mesenchymal and intermediate differentiation states
is an inherent property of G-2 cultures.
b) In vivo. We tested the tumor initiating potential of G-2 cells
by orthotopic transplantation into the left abdominal mammary
gland of nulliparous WAP-T recipient mice. 10
6 G-2 cells rapidly
formed palpable tumors (high-grade adenocarcinomas) in all
recipient mice (Table 1). The fewer cells we transplanted, the
longerwasthelagperiodand the higheritsvariation(Table1).Even
from 10 injected G-2 cells in 10 out of 12 recipient mice tumor
outgrowth was detected (Table 1), indicating a high frequency of
tumorigenic cells in the G-2 culture. Immunostaining analysis of
vimentin and Krt8/18 expression in G-2 cell derived tumors
(Figure 3A) revealed their close resemblance to poorly differentiated
(grade G3) WAP-T tumors (Figure 3B). While in low-grade WAP-T
tumors vimentin staining was mostly limited to septa and the
stromal compartment (Figure 3C), variable expression of vimentin
was also detectable in the epithelial compartment (represented by
Krt8/18) in high-grade WAP-T tumors (Figure 3B), indicating an
intermediate differentiation state of tumor cells in G-2 derived and
high-grade WAP-T tumors and an epithelial differentiation state of
tumor cells in low-grade WAP-T tumors. Co-staining for vimentin
and SV40-LT (expression of SV40-LT is limited to tumor cells)
allows to distinguish between stromal mesenchymal cells recruited
into the tumors and tumor cells expressing a mesenchymal or an
intermediate phenotype. In transplanted G-2 tumors (Figure 4A)
and high-grade WAP-T tumors (Figure 4B) we observed in addition
to the expected expression of vimentin in the stromal compartment
also the co-expression of vimentin and SV40-LT in individual
tumor cells. In contrast, in low-grade WAP-T tumors (Figure 4C)
vimentin and SV40-LT expression is restricted to stromal and
tumor epithelial compartments, respectively. Tumors grown from
transplanted G-2 cells (Figure 5A) recapitulated the distinctive
features of high-grade WAP-T tumors (Figure 5B), namely a
moderate proportion of cells co-expressing Krt14 and Krt8/18. In
contrast, in low-grade WAP-T tumors Krt8/Krt18 and Krt14 are
frequently co-expressed (Figure 5C).
In an additional experiment, 10
6 G-2 cells were transplanted into
fad pads of two non-transgenic BALB/c mice. In both mice large,
solid tumors grew after 4–6 weeks. Interestingly, the tumor cells were
largely devoid of epithelial markers, Epcam (Figure S2A) and
cytokeratins (Figure S2B, D), but strongly expressed vimentin (Figure
S2B, C), indicating that in non-transgenic mice transition into the
mesenchymal state is favored, possibly as a consequence of an
interaction with the host immune system. As the tumor cells continue
to express WAP-promoter driven SV40-LT (Figure S2C), it is likely
that mesenchymal differentiation in these cells was incomplete.
c) Gene expression profiling. The histomorphological
similarity between G-2 cell transplanted and WAP-T tumors
indicates that these tumors might also be closely related at the
molecular level. Based on the comparable expression of cIF
proteins, we also expected a close relationship between G-2 cells in
culture and in G-2 tumors. To test these assumptions, we
performed microarray expression profiling. Total RNA from G-
2, G-2C9 and G-2C11 cells, from two G-2 transplanted tumors, as
well as from four WAP-T-NP8 tumors representing four
histological grades (G1–G4) was analyzed on an Affymetrix
microarray platform (MOE430 2.0). Applying as significance
criteria the corr. P-value (Benjamini-Hochberg) ,=0.05, and a
fold change-cutoff 3, we identified 250 genes that were
differentially expressed between cell culture and tumor samples
(Table S1). Tightening the statistical criteria to a corr. P-value
,=0.01, only 24 genes satisfied these strict criteria. The 250
differentially expressed genes were further analyzed by the
EXPANDER program in order to identify over-represented GO
(gene ontology) categories and TF (transcription factor) binding
sites in their cis-regulatory regions [27]. The GO-enrichment
analysis was combined with hierarchical clustering, and the results
are presented in the heat map shown in Figure 6A. A significant
number of differentially expressed genes falls into the category of
immune defense genes, reflecting the fact that tumors contain a
certain contingent of immune cells, which is missing in cell culture.
The enrichment of genes related to immune processes correlates
well with the over-representation of binding sites for Elf1, a
transcription factor highly expressed in lymphoid cells [28], in the
promoter regions of the differentially expressed genes (P-value
,0.001). On the other hand, the cell culture samples are
distinguished by a higher expression of genes associated with
transcriptional regulation, e.g. Foxa2, Foxm1, Gata6, Hoxb2, Jmjd2c,
Ppargc1a, and Tle1, and developmental processes, e.g. Bmp4 which
is involved in the differentiation of mesenchymal cells. This
observation can be explained by adaptation of the transcriptional
network and of signaling pathways to cell culture conditions.
Taken together, the gene expression analysis demonstrated that G-
2 cells and tumors display more similarities than differences in
their gene expression program; the differences are mainly related
to their different biological context.
We reckoned that gene expression analysis should help to locate
G-2 cells within the mammary epithelial cell hierarchy. Using a list
of genes characteristic of luminal-ER
+, luminal-ER
2, and basal/
myoepithelial cells [29] (Table S1), and the gene expression profile
of the mammary gland of a parous BALB/c mouse (50 days post
weaning) as a reference, hierarchical cluster analysis again
revealed similarity between cell culture and tumor samples
Table 1. Tumorigenic properties of G-2 cells*.
Number of injected cells Tumors/injections Outgrowth latency (Mean of days ± SEM)
10
6 6/6 7.360.4
10
3 6/6 16.366.3
10
2 5/6 23.8610.9
10
1 10/12 44.8624.2
*10
6,1 0
3,1 0
2 and 10
1 G-2 cells were resuspended in 20 ml BD Matrigel Matrix and transplanted into the left abdominal mammary gland of virgin WAP-T-NP8 recipient
mice. The animals were palpated twice a week for tumor outgrowth.
doi:10.1371/journal.pone.0012103.t001
WAP-T Cancer Cell System
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comprising many genes from all three lineages became obvious.
Notably, Esr1 (coding for estrogen receptor alpha) is inside a
cluster of down-regulated ‘‘luminal-ER
+’’ genes, Vim (coding for
vimentin) in the cluster of non-regulated genes, Krt14 is located in
the cluster of up-regulated ‘‘basal’’ genes, whereas Krt5 together
with a number of other genes forms a cluster of down-regulated
‘‘basal’’ genes, consistent with the absence of Krt5 expression in
G-2 cell cultures and the rare occurrence of Krt5-postive cells in
WAP-T tumors (data not shown). Based on this analysis, we
conclude that the G-2 cell transcriptome likely is related to cells
committed to luminal-ER
2 differentiation. These cells could be
progenitors of luminal-ER
2 cells, which during commitment lost
the expression of prominent markers, like Esr1 and Krt5 – genes
functionally linked to luminal-ER
+ and basal cell lineages, and
became immortalized by SV40 proteins. However, final clarifica-
tion of their identity requires further studies.
Stemness of G-2 cells and their clonal derivatives
The high tumorigenic potential of G-2 cells prompted us to
study their CSC properties in more details. We performed a
number of standard assays to measure expression of a set of cell
surface markers, self-renewal, and generation of phenotypically
different progeny (collectively termed repopulation activity),
activity of aldehyde dehydrogenases, and colony forming potential.
a) Cell surface markers. Expression of certain cell surface
associated proteins, like integrins and GPI-anchored proteins, is
diagnostic for normal mammary stem cells and breast cancer stem
cells. By FACS we observed that nearly all G-2 cells express the
stemness-related markers CD29 (integrin beta 1) [30] (Figure 7A)
and CD44 (hyaluronate receptor) [31] (Figure 7B). A large fraction
of G-2 cells is positive for Epcam (epithelial cell adhesion molecule)
[31,32] (Figure 7C, left), which is co-expressed with CD24a and
CD49f (integrin alpha 6) proteins [30,33–35] (Figure 7C, right).
Another mammary progenitor-associated marker, CD61 (integrin
beta 3) [36], was detected on a large fraction of G-2 cells
(Figure 7D, left) and is also co-expressed with CD24a and CD49f
(Figure 7D, right). Therefore, we collectively termed the fraction of
G-2 cells co-expressing these cell membrane associated proteins as
the CD24a
high subset. Variations ranging from ,30% to ,90% in
the absolute number of cells in this subset were noted between
parental G-2 cells and clones (data not shown). Next, we observed
that the counterpart of the CD24a
high subset (Figure 7E, left) is
characterized by expression of the stem cell marker Sca1 [37]
(Figure 7E, right). Taken together, the G-2 culture comprises two
major distinct subsets, CD24a
high/Sca1
low and CD24a
low/
Sca1
high. SV40 transgene is equally transcribed in both subsets,
but the transcription of Krt14 and Krt18 genes is higher in
CD24a
high/Sca1
low cells (Figure S3A, B). We also observed by
qPCR analysis that Cd24a, Cd49f and Sca1 genes are transcribed in
both subsets (Figure S3C).
Recently, a small subset of Thy1
+/CD24
+ cells purified from
MMTV-Wnt-1 mammary carcinomas has been found to behave
like CSCs [33]. In the G-2 culture, the cells distinguished by Thy1
expression representan always variablysized population accounting
for less than 15% (Figure S4A). In contrast to the report by Cho et
al.[33], weobserved that Thy1
high cellsaremainlycontainedwithin
the CD24a
low/Sca1
high subset (Figure 8A); however a small fraction
Figure 3. Expression of the intermediate filament proteins in G-2 and WAP-T tumors. (A–C) Representative confocal images of tumor-
cryosections of a G-2 cell-derived tumor (A), and a high-grade (B) and a low-grade (C) endogenous WAP-T tumor stained with anti-vimentin (green)
and anti-keratin 8/18 (red) antibodies. The nuclei were stained with DRAQ5 (blue). The power insets are used to display co-expression of vimentin and
keratin 8/18 in G-2 and high-grade WAP-T tumors. The white dashed lines mark stromal structures. The confocal 3D-stacks were deconvoluted using
Huygens Essential software and reconstructed with the Imaris software. Scale bar: main picture: 30 mm; magnification: 3 mm.
doi:10.1371/journal.pone.0012103.g003
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growing cells, membrane-associated expression of Thy1 coincides
withthat ofSca1 (Figure S4B,left),whereasEpcam-positivecellsare
negative for Thy1 (Figure S4B, right).
When we compared microarray data for two clones, G-2C9 and
G-2C11,with parental G-2 cellsas a reference, we observed that the
list of genesweakerexpressedinthe subclones (FC.3;list ofgenesis
in Table S1) includes the Thy1 gene and genes coding for the
transcription factor Twist2, which promotes metastatic spreading
[38], the secreted protein Slit3, which is expressed in mammary
gland [39] and fetal lung mesenchyme [40], the lysyl oxidase (Lox)
involved in the crosslinking of collagens and the formation of a
premetastatic niche [41], and several collagen-coding genes (Col1a1,
Col1a2, Col5a1, Col5a2, Col8a1 and Col12a1). We reasoned that
transcription of these genes is linked to the Thy1
high phenotype.
Indeed, the Thy1
high subset is distinguished by a nearly exclusive
expression of Col1a1, Slit3, and Lox, and as expected from FACS
analysis, by Sca1 (Figure 8C). The transcription levels of Cd24a and
Cd49f genes are low, but clearly detectable in the Thy1
high subset
(Figure S4C). The data indicate that the Thy1
high subset represents
a cellular subset in an apparent mesenchymal differentiation state,
which, however, is not complete, as indicated by the transcription of
the Krt14 and Krt18 genes (Figure 8C) in addition to the Cd24a and
Cd49f genes. By immunostaining of cytospin preparations of FACS-
sortedcellswe wereable to show that only a minorpopulation ofthe
Thy1
high cells is clearly positive for cytokeratins, as opposed to the
prominent expression of vimentin in all Thy1
high cells (Figure 8D;
Figure S4D). On the other hand, cytokeratins are detectable in
nearly all Thy1
low cells, whereas (a generally reduced) positive
vimentin immunostaining is limited to roughly two-thirds of the
Thy1
low cells (Figure 8D; Figure S4D). The few Thy1
high cells
expressing Krt18 may represent either contaminating cells, or cells
which are in process of transition towards the Thy1
low-state (see
below). Notably, despite underrepresentation of cytokeratin-positive
cells within the Thy1
high subset, the overall transcription of Krt14
and Krt18 genes is only 4-fold stronger in Thy1
low cells than in
Thy1
high cells (Figure 8C).
To analyze Thy1 expression in WAP-T and G-2 tumors the
samples were immunostained with a Thy1-specific antibody. In
low-grade WAP-T tumors we noted that Thy1 as well as Sca1
expression is mostly restricted to the stromal compartment and to
adjacent tumor cells (Figure 8E). In high-grade carcinomas a
subset of cells adjacent to the stroma, demarked by the strong
expression of Thy1, expresses either Thy1 or Sca1 or both markers
(Figure 8F). Similarly, in tumors grown from G-2 transplanted
cells the membranes of cells adjacent to Thy1-positive stromal
cords are weakly stained with the Thy1 antibody (Figure 8G). The
tumor origin of Thy1-expressing cells was further confirmed by co-
staining with the SV40-LT specific antibody (Figure 8H), which
we used to distinguish between tumor cells and cells provided by
recipient mice.
b) Repopulation activity. Next, G-2 cells were separated
according to Thy1 expression and after 5 days in culture re-
analyzed by FACS. The Thy1
high subset repopulated both Thy1
subsets (Figure 9A, left), thereby creating a cell population that was
nearly identical to the initial G-2 culture with regard to expression
Figure 4. Expression of the intermediate filament protein vimentin and the SV40-LT transgene in G-2 and WAP-T tumors. (A–C)
Representative confocal images of tumor-cryosections of a G-2 cell-derived tumor (A), a high-grade (B) and a low-grade (C) endogenous WAP-T
tumor stained with anti-vimentin (green) and anti-SV40-LT (red) antibodies. The nuclei were stained with DRAQ5 (blue). The power insets are used to
display co-expression of vimentin and SV40-LT in G-2 and high-grade WAP-T tumors. The white dashed lines mark stromal structures. The confocal
3D-stacks were deconvoluted using Huygens Essential software and reconstructed with the Imaris software. Scale bar: main picture: 50 mm;
magnification: 6 mm.
doi:10.1371/journal.pone.0012103.g004
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low cells
remained in the Thy1
low state (Figure 9B, left), but generated a
population of cells consisting of Epcam
high and Epcam
low subsets
(Figure 9B, right). The observed limited repopulation activity of
Thy1
low cells indicates that regeneration of the Thy1
high subset
either requires longer cultivation or depends on culture conditions.
The latter possibility is supported by a significant decrease of the
Thy1
high subset as a function of increasing cell density (Figure 9C).
Accordingly, the lower the cell density, the more Thy1
high cells
were present in the cell culture. This could explain the significant
variations in the proportion of Thy1
high cells observed between
passages (data not shown) and within G-2 clones (Figure S4A).
The data indicate that the Thy1
high cells represent a CSC-like
subset in a G-2 culture, which in terms of hierarchy seems to be
above the CD24a
high and CD24a
low subsets. However, the latter
subsets also possess a repopulation activity: after 3 days in culture,
the CD24a
high/CD49f
high cells repopulated the CD24a
low/
CD49f
low subset to nearly the same ratio as initially measured in
the parental G-2 culture (Figure 10A). Individually cultured
CD24a
low/CD49f
low cells repopulated the CD24a
high/CD49f
high
compartment with slower dynamics: 7.9% CD24a
high cells were
detected after 3 days in culture, but their number increased by
about 3-fold after additional 2 days (Figure 10A). Correspondingly,
CD24a
high/CD49f
high cells (Figure 10B, right) are less efficient
than CD24a
low/CD49f
low cells (Figure 10B, left) in regenerating
the initial proportion of Thy1
high cells. Similar repopulation
kinetics by individually cultured CD24a
high and CD24a
low subsets
were observed using the G-2 derived cell clones (Figure S5).
The different kinetics for the accumulation of the complemen-
tary cellular subset in cultures of CD24a
high/CD49f
high and
CD24a
low/CD49f
low cells, respectively, pointed to a potential role
of intercellular communication. To substantiate this idea, 5610
3
and 5610
4 FACS-sorted CD24a
low/CD49f
low G-2 cells were
plated per well, and after 5 days in culture expression of the Cd24a,
Cd49f and Sca1 genes was quantified by qPCR. While the RNA
levels of the Cd24a and Cd49f genes positively correlated with
increased cell density, expression of the Sca1 decreased as a
function of cell density (Figure 10C).
The importance of intercellular communication in subset
repopulation was further supported by co-culture experiments.
The CD24a
low/CD49f
low subset was labeled with the lipophilic
dye DiI and 1610
4 labeled cells were either cultured separately, or
were plated at a 1:1 ratio with non-labeled CD24a
high/CD49f
high
cells. After 3 days in culture, the DiI-positive cells (Figure 11A and
B, left) were analyzed by FACS for expression of CD24a and
CD49f (Figure 11A and B, right). Whereas 24.7% of the separately
cultured DiI labeled CD24a
low/CD49f
low cells became spontane-
ously positive for CD24a and CD49f (Figure 11A, right), this
fraction increased to 41.7% during co-culture with non-labeled
CD24a
high cells (Figure 11B, right). In a complementary
experiment, the subset of eGFP-expressing Epcam
low G-2 cells
was cultured either alone (1610
4 cells per well) (Figure 11C, left),
or mixed in a 1:1 ratio with non-transfected Epcam
high G-2 cells
(Figure 11D, left). After 3 days in culture, 8.9% of the eGFP-
positive cells revealed strong expression of Epcam (Figure 11C,
right), while the fraction of Epcam-expressing eGFP-positive cells
Figure 5. Expression of the cytokeratins in G-2 and WAP-T tumors. (A–C) Representative confocal images of tumor-cryosections of a G-2
cell-derived tumor (A), a high-grade (B) and a low-grade (C) endogenous WAP-T tumor stained with anti-keratin 8/18 (green) and anti-keratin 14 (red)
antibodies. The nuclei were stained with DRAQ5 (blue). The power insets are used to display co-expression of keratin 8/18 and keratin 14 in G-2, high-
grade and low-grade WAP-T tumors. The confocal 3D-stacks were deconvoluted using Huygens Essential software and reconstructed with the Imaris
software. Scale bar: main picture: 50 mm; magnification: 6 mm.
doi:10.1371/journal.pone.0012103.g005
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high
G-2 cells (Figure 11D, right).
c) Metabolic markers. High ALDH activity has been
described as a marker for normal stem/early progenitor cells in
different organs in human and mice, and proposed to be a specific
marker for normal and malignant human mammary stem cells
[42]. We therefore tested G-2 cells for ALDH activity using the
AldefluorH reagent. The efficient retention of the AldefluorH
reagent (Bodipy-aminoacetaldehyde; BAAA) after conversion into
the charged product BAA (BODIPY-aminoacetate) distinguished
around 12–17% of the G-2 cells (ALDH
bright, high BAA
fluorescence) from intermediate and low (ALDH
dim) fluorescing
G-2 cells (Figure 12A, right panel). The specificity of this reaction
was verified by applying the ALDH inhibitor DEAB, which
completely blocked BAAA conversion (Figure 12A, left panel).
Combining the AldefluorH reaction with the staining of cell surface
markers, a significant overlap between the CD24a
high (Figure 12B,
left panel) and Sca1
high (Figure 12B, right panel) subsets and
ALDH
bright and ALDH
dim cells was detected, indicating that the
ALDH
bright and ALDH
dim compartments represent a mix of
CD24a
high and CD24a
low subsets. To test the repopulation
properties of ALDH
bright and ALDH
dim populations, FACS-
sorted cells were propagated separately (5610
5 cells per well) and
then re-analyzed by FACS using the AldefluorH reagent. After 2
days in culture the ALDH
bright (Figure 12C, right panel) and
ALDH
dim (Figure 12C, left panel) G-2 cellular subsets were able to
almost perfectly regenerate the initial profile of ALDH activity in
the G-2 culture, although the repopulation activity of ALDH
bright
cells seemed to be slightly slower. In line with the in vitro data,
transplantation of ALDH
bright and ALDH
dim subsets did not
reveal substantial differences in their tumorigenic activity
(Figure 12D). Furthermore, no significant differences in the
tumorigenic activity was observed between ALDH
bright and
ALDH
dim primary WAP-T tumor cells, and tumors arising from
transplanted cells were similar to their parental tumors in histology
and expression of epithelial markers (data not shown). The
Figure 6. Gene expression profiling of G-2 cells and tumor samples. (A) 250 genes differentially expressed in cultured G-2 cells and
endogenous WAP-T or G-2 cell derived tumors (Table S1) were used to generate a heat map. Enriched GO categories are shown as bar diagrams
corresponding to higher or lower expressed gene clusters in the respective sample group. Color-coding and the height of a bar represents the
statistical significance (-log10(p-value)) of the observed enrichment of the respective GO categories. (B) Genes characteristic for luminal-ER
+, luminal-
ER
2, and basal/myoepithelial cells were used to generate heat maps. Gene expression data obtained for cell culture (G-2, G-2C9 and G-2C11 cells) and
tumor samples (two G-2 transplanted tumors and four WAP-T-NP8 tumors representing four histological grades) were used for this analysis. Gene
expression intensities of a mammary gland of a parous BALB/c mouse (50 days post weaning) were used as a reference. Prominent gene clusters
(Krt14, Vim, Krt5, Krt18, and Esr1) are highlighted by yellow boxes. The expression values are color coded: red – high expression, blue – low expression.
doi:10.1371/journal.pone.0012103.g006
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stem cell marker in WAP-T mammary carcinomas.
d) Colony forming activity. As colony formation is
considered to be a criterion inherent to stem cells, G-2 cells and
cells of the G-2 cell derived clones C9 and C11, respectively, were
seeded in soft agar (10 and 100 cells per well). Table 2 shows that
all tested cells have a high capacity for clonal growth, as about
80% of the cells formed colonies. About 50–70% of the colonies
could be expanded in culture, while the rest did not grow.
The repopulation activity of G-2 cells is regulated by
differentially expressed sets of transcription factors
We hypothesized that the repopulation activity of G-2 cell
subsets depends on the transcriptional competence of each subset,
derived primarily from the expression of certain transcription
factors (TFs). To substantiate this hypothesis, we first compiled a
list of TFs (total of 73; see Table S1) selected by literature
screening and by their expression in G-2 cells, in normal tissue,
and in tumor samples. Hierarchical clustering analysis (Figure 13A)
demonstrated the high similarity in TF expression between G-2
cell cultures and tumor samples and revealed two large gene
clusters containing genes whose expression in comparison to
normal mammary gland is either significantly reduced, e.g. Esr1,
Cebpa, Sox17, Sox18, Hoxc6, Id4, Pparg, and Foxa1, or enhanced, e.g.
Ehf, Elf5, Etv1, Etv4, Etv5, Hmga1, Foxc1, Foxm1, Sox10 and
Tcfcp2l1. We considered that the TFs from the latter group are
essential for differentiation into the phenotypic subsets observed in
G-2 cultures. As shown by qPCR analysis, expression of known
regulators of normal and tumor mammary epithelial cell fate and
function, namely Ehf [43], Elf5 [44], Etv5 [45], and Foxc1 [46] is
stronger in the CD24a
high subset (Figure 13B), whereas the
CD24a
low subset is distinguished by a higher expression of the
Twist2 gene (Figure 13B), whose product has a function in EMT
[38]. Notably, the expression of Sox10, a member of the SOX
(SRY-related HMG-box) family of TFs, was significantly increased
in the Thy1
low compared to the Thy1
high subset (Figure 13C), but
was only slightly higher in the CD24a
low subset as compared to the
CD24a
high subset (Figure 13B). The finding suggested a role for
Sox10 in regulating the differentiation state of G-2 cells. Indeed,
siRNA mediated depletion of Sox10 resulted in a significant up-
regulation of Twist2, but in no or only a slight regulation of
epithelial-specific TFs (Figure 13D), indicating that Sox10
probably has a function in dampening EMT progression in G-2
cells via repression of Twist2. In support, 5 days after transfection
of cells with Sox10 siRNA, the proportion of Thy1
high cells
increased several folds as measured by FACS (Figure 13E). In
conclusion, we identified Sox10 as a transcription factor
controlling the differentiation states of G-2 cells.
Discussion
The current CSC model provides a conceptual framework for
studying tumors as cellular systems that in many aspects resemble
normal tissues. In this regard, the evolution of the concept for
normal stem cells also has implications for the CSC model. In
normal tissues, the hierarchical organization and irreversible
commitment for distinct lineages has been disputed. As an
alternative, it has been suggested that phenotypic plasticity is a
basic property of the stem cell state [47]. Extending the meaning
of plasticity, it has been questioned that normal and cancer stem
cells exist as an entity defined by discrete molecular properties, but
rather together with the population of committed progenitors and
their differentiated progeny comprise a homeostatic ‘‘stem cell
system’’ where the cellular composition is regulated by feed-back
mechanisms [10]. Our and other studies [48–50] suggest that, at
least in established clonal cell cultures, but most likely also in
tumor tissue, heterogeneity of differentiation states is an intrinsic
property of what we term the ‘‘cancer cell system’’ (CCS)
(Figure 14). We propose that the G-2 CCS is mainly populated
by cells in three differentiation states: quasi-epithelial, intermedi-
ate, and quasi-mesenchymal. The differentiation states are
operationally distinguished by a combination of cell surface
associated proteins, a specific set of transcription factors and by
the composition of cytoskeletal intermediate filaments, and are
associated with the ability for self-renewal and uni- or bi-
directional interconversion. We assume that transitions between
differentiation states and self-renewal within the G-2 CCS are
regulated by intercellular communications, autocrine/paracrine
signaling and metabolic parameters (e.g. oxygen and metabolites
supply). We expect that combinations and individual contribution
of regulatory factors and circuits are different under in vitro and in
vivo settings; however, their interplay results in the formation of
comparable CCSs.
‘‘Cell of tumor origin’’ defines the cancer cell system
We think that in any CCS, the variability of differentiation
states is determined by the origin of the tumor cells from certain
tissue-restricted ‘‘founder’’ cells. As transforming events may hit
any cellular compartment in the mammary epithelial cell
hierarchy [51], but most likely the stem cell compartment [52],
one has to expect that different scenarios of tumor initiation and
progression can be realized and, consequently, different CCS can
be created. For example, expansion of transiently existing or
minor populations of gradually committed progenitors will result
in the generation of differently populated CCS, which due to their
origin from the same ‘‘stem cell system’’ may be equipped with
many related features, like expression of differentiation-specific
genes, but nevertheless deviate in their biological behavior. An
illustration for a tumorigenic expansion of a minor population is
the finding that in ‘‘luminal’’-type Wap-Cre;EN mammary
carcinomas [24] and low-grade WAP-T tumors (this study), the
embryonic K8
+K14
+ cellular subset [53] is significantly expanded,
while in the adult normal mammary gland K8
+K14
+ cells
constitute a rare population that overlaps with CD61
+ luminal
progenitors [24]. Expansion of a cell population expressing a mix
of ‘‘basal’’ and ‘‘luminal’’ cytokeratins was also observed in
mammary epithelium with impaired Notch signaling [54] and
depleted of the PDZ domains-containing scaffold protein Par3,
which regulates cell polarity [55].
The co-expression of vimentin and cytokeratins in individual
cells in high-grade WAP-T tumors and in G-2 cultures probably
can also be attributed to the expansion of transformed,
vimentin-expressing cells normally present in the mammary
epithelial ‘‘stem cell system’’. Indeed, significant vimentin
Figure 7. Expression of stemness-related cell surface markers in G-2 cells. (A, B) Representative FACS dot plots showing the expression of
CD29 (A) and CD44 (B) in G-2 cultured cells. (C) Representative FACS dot plots showing the expression of Epcam (C, left) in cultured G-2 cells and the
distribution of CD24a and CD49f (C, right) within the Epcam
high cell population. (D) Representative FACS dot plots showing the expression of CD61
(D, left) in cultured G-2 cells and the distribution of CD24a and CD49f (C, right) within the CD61
high cell population. (E) Representative FACS dot plots
showing the expression of CD24a and CD49f in cultured G-2 cells (E, left) and within the Sca1
high (E, right) cell population.
doi:10.1371/journal.pone.0012103.g007
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PLoS ONE | www.plosone.org 11 August 2010 | Volume 5 | Issue 8 | e12103Figure 8. Properties of G-2 cell subsets differing in expression of Thy1. (A, B) Representative FACS dot plots showing the expression of Sca1
(A) and CD24a (B) in the Thy1
high population of cultured G-2 cells. (C) Relative quantitation of gene expression by real-time qPCR in the Thy1
high and
Thy1
low subsets. Each assay was done in triplicate and raw RQ values were calculated by normalizing to the Gapdh gene. The Thy1
high subset was
selected as calibrator. (D) Cytospin preparations of FACS-sorted Thy1
high and Thy1
low G-2 cells were stained for keratin 18 (D, upper panels) and
vimentin (D, lower panels). (E, F, G) Representative confocal images of a low-grade (E) and a high-grade (F) WAP-T tumors as well as of a G-2 (G)
tumor. Cryosections of tumor samples were stained with anti-Thy1 (green) and anti-Sca1 (red) antibodies. (H) Representative confocal image showing
expression of Thy1 (green) and SV40-LT (red) in G-2 tumor. Individual color channels are shown. Arrows mark the cells co-expressing Thy1 and SV40-
LT. Nuclei were stained with DAPI (D) or DRAQ5 (E, F, G, H). The white dashed lines mark stromal structures. Confocal 3D-stacks were deconvoluted
using Huygens Essential software and reconstructed with the Imaris software. Scale bar: D:7 5mm; E, F, G and H:5 0mm.
doi:10.1371/journal.pone.0012103.g008
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unit) cell population that is responsible for mammary tissue
regeneration upon transplantation into the cleared fat pad [56].
The MRU subset is a rare population of mammary epithelial
cells co-expressing CD24a and CD49f, but lacking Sca1expres-
sion [56]. Since vimentin is expressed during mammary
morphogenesis [57] and is associated with a motile phenotype
[58], it is conceivable that vimentin marks a subset of non-
constrained cells required for tissue maintenance. The predom-
inant intermediate differentiation state of high-grade WAP-T
tumors likely results from the oncogenic transformation of this
cellular subset. In such a CCS, the ability for bidirectional
interconversion (plasticity) between differentiation states may
a c c o u n tf o rab e t t e ra d a p t a b ility to microenvironmental
conditions and eventually provide a basis for tumor aggressive-
ness (e.g. rapid growth and metastatic behavior).
Figure 9. Repopulation activity of the Thy1
high/low G-2 cell subsets. (A, B) Repopulation activity of the Thy1
low and Thy1
high subsets. FACS-
sorted Thy1
high (A) and Thy1
low (B) G-2 cells were cultured for 5 days in 6-well plates and re-analyzed by FACS for Thy1 expression (A, left; B, left). The
distribution of Epcam within the respective Thy1
high and Thy1
low subsets was then determined by further FACS-analysis (A, B, right panels). (C) Cells
of the G-2 derived clones K2, C9 and C11 were plated at low (1610
4), intermediate (5610
4) and high (1610
5) density in 6-well plates and analyzed 2
days later for Thy1 expression by FACS (n=3). The representative FACS dot plots are shown.
doi:10.1371/journal.pone.0012103.g009
Figure 10. Repopulation activity of G-2 cell subsets differing in expression of CD24a/CD49f. (A) Repopulation activity of G-2 cell subsets
differing in expression of CD24a and CD49f. CD24a
high/CD49f
high and CD24a
low/CD49f
low subsets were gated to exclude any overlap (left FACS dot
plot). 5610
4 sorted cells were transferred back into culture (6-well plates) and the composition of the cell culture was re-analyzed for the same
markers 3 and 5 days later by FACS. Note that in the resulting four FACS dot plots the gates of CD24a
low/CD49f
low cells are restricted by the
magnification. The percentages of events in each gate (quadrant) are given. (B)5 610
4 sorted CD24a
high/CD49f
high and CD24a
low/CD49f
low G-2 cells
were transferred back into culture (6-well plates) and analyzed 5 days later for expression of Thy1 by FACS. The representative FACS dot plots are
shown. (C) The CD24a
low/CD49f
low subset was sorted and plated at low (5610
3 cells per well) and high (5610
4 cells per well) density in 6-well plates.
After 5 days in culture, expression of Cd49f, Cd24a, and Sca1 was quantitated by real-time qPCR. The experiment was performed in duplicate and
repeated twice.
doi:10.1371/journal.pone.0012103.g010
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of mammary tumors, e.g. WAP and MMTV, limits the cellular
compartments of the mammary ‘‘stem cell system’’ that can be
deregulated and transformed by oncogene expression. This results
in the outgrowth of phenotypically similar tumor types, which,
however, may differ in their genetic and epigenetic traits and more
importantly, represent different CCSs. Therefore, it is not
surprising that tumorigenic subpopulations in mammary carcino-
mas induced by different oncogenes, driven by different promoters
or induced by loss of tumor suppressors in mammary epithelial
cells are differing in their profiles of cell surface markers: e.g. the
Sca1
+ subset in BALB-neuT mice [37], the CD29
HCD24
H subset
in p53-null mammary tumors [30] and in mammary tumors from
BRCA1 conditional knockout mice [35], and the CD61
+ subset in
MMTV-Wnt-1 mice [36]. A related ambiguity of cell surface
markers (e.g. Sca1) for the enrichment of CSCs has been recently
reported for three mouse models of lung adenocarcinoma [59]. In
line with these observations, it is also questionable to generally
associate other stemness-related properties, e.g. drug efflux activity
that characterizes a so-called ‘‘side population’’[60] and high
aldehyde dehydrogenase activity [61] with the tumorigenic
potential. In G-2 cell cultures and primary cells purified from
WAP-T tumors, for example, no ‘‘side population’’ as measured
by efflux of the Hoechst dye could been observed (data not shown),
and no correlation was found between metabolic Aldefluor
conversion and tumorigenic activity. Under these circumstances
the application of cell surface or metabolic markers maybe
operationally useful for the enrichment of distinct cellular subsets.
However, without knowledge about the function of these markers
in the respective cellular context it is difficult to conceive the
biological properties of these cellular subsets, and to assess their
association with a CSC potential and their position in the
respective CCSs.
Differentiation states within ‘‘cancer cell system’’ in cell
culture and in vivo
According to our definition, the term ‘‘cancer cell system’’ is
applicable to cells growing in culture as well as to cells forming
primary and transplanted tumor. Due to the inherent differences
between in vitro and in vivo conditions some limitations must be
considered that may cause significant variations in the composition
and properties of a CCS. In cell culture, irreversibly differentiated
cells inevitably get lost during cell passage, as terminal differen-
tiation presupposes an exit from the cell cycle, whereas in vivo
terminally differentiated cells remain in the tumor and may
contribute to the formation of the stromal compartment. Thus cell
culture leads to the selection of actively proliferating cells capable
of generating viable progeny under cell culture conditions. This
may explain the gene expression differences measured between G-
2 cell culture and tumor samples. In this respect, it is likely that the
pronounced co-expression of Krt14 and Krt8/18 proteins in G-2
culture, but not in G-2 tumors, is attributed to selection in cell
Figure 11. Repopulation activity of G-2 cell subsets depends on cellular interactions. (A, B) CD24a
low/CD49f
low cells were labeled with DiI
and 1610
4 labeled cells were either cultured separately (A), or plated at a 1:1 ratio with non-labeled CD24a
high/CD49f
high cells (B) in 6-well plates.
After 3 days in culture, DiI labeled cells were analyzed for expression of CD24a and CD49f by FACS. (C, D)1 610
4 cells of the Epcam
low subset
expressing eGFP were either cultured alone (C) or plated at a 1:1 ratio with G-2 cells lacking eGFP from the Epcam
high subset (D) in 6-well plates. After
3 days in culture, GFP positive cells were analyzed for Epcam expression by FACS. The representative FACS dot plots are shown.
doi:10.1371/journal.pone.0012103.g011
WAP-T Cancer Cell System
PLoS ONE | www.plosone.org 14 August 2010 | Volume 5 | Issue 8 | e12103culture for a pro-proliferative function of Krt14. Such a
proliferation-promoting role of Krt14 has been demonstrated in
transgenic mice overexpressing Krt14 in pulmonary epithelium
[62]. However, how cytoskeletal Krt14 regulates cellular prolifer-
ation is not yet known. Interestingly, during primary cell culture of
normal mammary epithelial cells a transition to co-expression of
both lineage-specific cytokeratins occurs in colonies derived from
CD24
high cells, which before plating expressed only the ‘‘luminal’’
cytokeratins [63].
In culture, the G-2 CCS is populated by proliferating cells in
quasi-epithelial, intermediate, and quasi-mesenchymal differenti-
ation states (Figure 14). The latter state is represented by
expression of Thy1, is reversible and can most likely transit
directly into a quasi-epithelial state. How the Thy1-positive cells
are (re-)generated in G-2 culture depleted by FACS of Thy1-
expressing cells is unclear and needs to be explored. We speculate
that under certain circumstances (e.g. at low plating density) the
transition from an intermediate to a quasi-mesenchymal state may
take place (Figure 14). Thy1, a marker of myoepithelial and
fibroblastic cells [64,65], has been linked to mammary CSCs, as a
small subset of Thy1
+/CD24
+ cells, comprising 1%–4% of the
tumor cells purified from mammary carcinomas in MMTV-Wnt-1
mice, has been found to behave like CSCs [33]. In the G-2 cell
culture, Thy1 expression characterizes a subset of cells mostly
located within the CD24a
low/Sca1
high compartment. However,
roughly 5% of Thy1
high cells overlap with the CD24a
high subset.
These double-positive (Thy1
high/CD24a
high) cells might be related
to the corresponding subset in MMTV-Wnt-1 tumors; however,
their paucity in G-2 cultures argues against this. Noteworthy, in
WAP-T tumors Thy1-expressing cells are mostly located within or
close to fibroblastic stroma, which likely originates from recruited
normal mesenchymal stem cells [66] and probably provides a
seeding niche for tumor cells undergoing mesenchymal differen-
tiation. Future studies of Thy1-expressing cells in G-2 culture and
WAP-T tumors should provide new insights into their role in the
phenotypic composition of CCSs.
Emerging evidence indicates that the host microenvironment,
represented by a combination of immunologic, trophic and local
Figure 12. Properties of G-2 cell subsets differing in aldehyde dehydrogenase activity. (A) Representative FACS dot plots showing ALDH
activity of G-2 cells (A, right panel) measured with the Aldefluor reagent (BAAA). To define the ALDH
bright gate, G-2 cells were stained with the
Aldefluor reagent in presence of the ALDH inhibitor DEAB (A, left panel). (B) Representative FACS dot plots showing the expression of CD24a (B, left
panel) and Sca1 (B, right panel) in the ALDH
bright subsets. Fluorescence-values of the Aldefluor-channel (FITC) and the CD24a-channel (PE) were
compensated before analysis of the CD24a
high and Sca1
high fluorescence. (C) Repopulation activity of the ALDH
bright and ALDH
dim subsets. 5610
5
FACS-sorted ALDH
bright and ALDH
dim cells were individually plated in 6-well plates. After 2 days in the culture, cells were analyzed for ALDH activity by
Aldefluor staining and FACS. (D) The graph shows growth curves of tumors arising upon transplantation of ALDH
bright and ALDH
dim G-2 cells into the
left abdominal mammary gland of virgin syngeneic mice (WAP-T-NP8). The dark and light curves, respectively, represent tumor growth kinetics of 10
4
and 10
2 transplanted cells in individual recipient mice.
doi:10.1371/journal.pone.0012103.g012
Table 2. Colony forming potential of G-2 cells and clones*.
Colony forming cells (%)
Cell line 10 cells 100 cells
G-2 86.7611.5 87.366.8
G-2C9 83.865.8 91.064.6
G-2C11 80.0610.0 87.065.3
*10 and 100 cells were seeded in soft agar (6-well plates) in triplicates. The
colonies were counted after 2 weeks.
doi:10.1371/journal.pone.0012103.t002
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differentiation states of tumor cells. For instance, in transplanted,
non-transgenic mice CD8
+-T lymphocytes stimulated an incom-
plete EMT of transplanted mammary epithelial tumor cells [67]. It
is assumed that immunoediting resulted in the selection of tumor
cells that lack expression of the transgene (MMTV-promoter
driven neu protein) and display an intermediate differentiation
state, which however can be reversed back to an epithelial state
upon re-transplantation into syngeneic mice [68]. In our model,
we observed that G-2 tumors grown in non-transgenic BALB/c
mice display a mesenchymal phenotype; however, tumor cells
retained expression of the WAP-promoter driven SV40 LT
protein. The identity and properties of these cells, especially the
contribution of immune cells to the phenotypic plasticity of
transplanted G-2 cells, is a matter of ongoing studies.
Furthermore, tumor vascularization not only serves for
transport of metabolites and humoral factors, but also provides
another regulatory mechanism of tumor cell differentiation based
on the emerging role of oxygen. Depending on local oxygen
concentration the differentiation state of tumor cells is adjusted to
one that is more adequate with respect to metabolic requirements.
Upon moderate hypoxic conditions epithelial tumor cells undergo
EMT [69], which is transcriptionally regulated by Hif-1alpha and
its downstream target Twist1 [70]; conversely, hyperbaric oxygen
treatment triggers a reversed process, MET [71].
As immune cells are absent in culture and oxygen supply is
constant, it is obvious that the differentiation states of G-2 cells are
regulated by intrinsic factors. In G-2 culture around 80% of the
cells are colony-forming, but not each colony will form a CCS
(around 50% of G-2 cell colonies are CCS-forming). Assuming
that a newly formed colony is composed of nearly identical cells
which with respect to their differentiation state recapitulate the
phenotype of the mother cell, possibly a restriction point controls
the transition from a monomorphic colony to a heterogeneous
CCS. The number of cells in a colony might be crucial for the
transition into a more complex state where cells in different
differentiation states cooperate to maintain the whole system.
When a certain critical concentration of cells and secreted factors
is reached, the transit of a colony from one state to another may be
triggered. In support of this idea, we demonstrate that co-culture
of complementary cellular subsets greatly influences the repopu-
lation activity of their counterparts. Although we did not address
in this study the question which signaling pathways are involved in
the regulation of the G-2 CCS, we observed in preliminary
Figure 13. Expression of selected transcription factors in G-2 cells. (A) Hierarchical cluster analysis of microarray gene expression data. 73
genes coding for transcription factors (Table S1) were selected to generate a heat map. Gene expression log2-ratios are displayed with gene
expression intensities of the mammary gland of a parous BALB/c mouse (50 days post weaning; Inv50pw) serving as reference. The relative
expression values are color coded: red – high expression, blue – low. (B–D) Relative quantitation of gene expression by real-time qPCR in CD24a
high/
CD49f
high and CD24a
low/CD49f
low (B), Thy1
high and Thy1
low (C) G-2 cell subsets, and G-2 cells transfected with Sox10 or control siRNA (D),
respectively. Each assay was done in triplicate, and raw RQ values were calculated by normalizing to the Gapdh gene. (E) siRNA-mediated Sox10
depletion increases the number of Thy1-expressing cells. G-2 and G-2C10 cells were transfected with Sox10 or control siRNA and were analyzed for
Thy1 expression by FACS after 5 days culture. A representative analysis is shown.
doi:10.1371/journal.pone.0012103.g013
WAP-T Cancer Cell System
PLoS ONE | www.plosone.org 16 August 2010 | Volume 5 | Issue 8 | e12103experiments that the differentiation states of G-2 cells are
influenced by multiple, synergistically or antagonistically acting
pathways including interferon-, BMP- and HGF-mediated signal-
ing cascades. Further work is needed to explore the contribution of
these pathways in more details.
Consequently, we propose that in vivo, upon transplantation of
single cells, the probability for tumor outgrowth is determined by
the generation of a minimal CCS, which is determined by a
combination of intrinsic (e.g. intercellular communications) and
external factors (e.g. interactions with the immune system and
supply of oxygen). Similarly, we think that establishment of a
stable ‘‘cancer cell system’’ at the seeding site most likely is the
decisive event for the outgrowth of a metastatic tumor, where
similar as in the development of the primary tumor, mesenchymal
and epithelial cells cooperate to create a niche and generate a
proliferative cell pool.
Role of the gene regulation network in the maintenance
of a ‘‘cancer cell system’’
In terms of mathematical formalism, any cellular system is
maintained via a metastable state of a gene regulation network
(GRN) that at the level of a single cell is proficient to restore the
phenotypic heterogeneity of the whole system [72]. The key
components of any GRN are transcription factors, with their
combination shaping the phenotype of a single cell and the
behavior of any cellular system. TFs regulate the differentiation
state and biological properties of tumor cells and represent possible
targets for cancer therapy. The activity of a single TF may
profoundly change the tumor cell phenotype, as for example,
RNAi-mediated knockdown of Klf17 (Kru ¨ppel-like factor) pro-
motes EMT and lung metastasis of 168FARN cell line, whereas
overexpression of Klf17 in the metastatic 4T1 cell line consider-
ably limits their metastatic potential [73]. In a related study Twist1
was identified as a positive regulator of the metastatic behavior of
4T1 cells [74]. It is noteworthy that 4T1 and 168FARN are cell
lines derived by different culture protocols from a single mammary
tumor spontaneously arising in BALB/cfC3H mouse [75]. These
cell lines provide an example of how the differences in GRN
composition contributes to creation of a distinct cellular phenotype
in a context of related genetic background.
In the present work we showed by qPCR that FACS-separated
G-2 cellular subsets differ in the transcription of genes linked to the
respective subset, e.g. Cd24a, Cd49f, Sca1, and do express, though
at different levels, the transcription factors associated with
epithelial (e.g., Ehf, Etv5 and Elf5) and mesenchymal (e.g., Twist2)
differentiation gene expression programs. Expression of these TFs
obviously provides the basis for a competent transcriptional
network, which specifies and maintains the self-reproducing G-2
CCS. As a notable component of the G-2 GRN we identified the
transcription factor Sox10, known as a glial and neural crest cell
fate regulator [76], and demonstrated that perturbation in the
expression of a single component of the GRN can significantly
Figure 14. Schematic overview of the G-2 ‘‘cancer cell system’’. The cellular composition of the assumed G-2 cancer cell system is determined
by three interconvertible differentiation states: quasi-epithelial, intermediate, and quasi-mesenchymal. These states are characterized by the
expression of a combination of cell surface associated proteins (CD24a, CD49f, CD61, Epcam, Sca1, Thy1), a specific set of transcription factors and by
their cytoskeletal composition (Krt14, Krt18, vimentin), as well as by their ability to self-renew. Cells in all three states express the CD44 and CD29
proteins on their surfaces. The existence of the (self-sustaining) G-2 system depends on the expression SV40 LT, driven by the WAP-promoter, which
is under control of epithelial transcription factors (TFs). Shut off of epithelial TFs leads to loss of SV40 LT expression and irreversible transitiont oa
completely mesenchymal differentiation state. The existence of an irreversible epithelial differentiation state has not been proven, however, cannot
be excluded. Transition rates between differentiation states and self-reproduction are determined by kinetic parameters which depend on
intercellular communications and/or autocrine/paracrine factors as well as on the activity of the inversely expressed transcription factors (e.g. Sox10
and Twist2). The variable width of arrows should illustrate the observed differences in rates of transitions, e.g. the transition into quasi-mesenchymal
is a rare (unfavorable) event, whereas the reverse transition readily takes place in culture. The figure was drawn using an open-source vector graphics
program Inkscape.
doi:10.1371/journal.pone.0012103.g014
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Sox10 in the regulation of EMT/MET in G-2 CCS as well as the
transcriptional targets of Sox10 remains to be elucidated. Also the
question whether Twist2 is transcriptionally regulated directly or
indirectly by Sox10 is still open and needs further investigations.
An important prerequisite for the interconversion between
complementary subsets is a transcriptional permissiveness of those
genes whose transcription characterizes the respective differenti-
ation state. The creation of the permissive state of a differentiation-
specific gene might rely on mechanisms related e.g. to activation of
primary response genes, which are regulated at the level of
transcript elongation and processing [77]. Alternatively, transcrip-
tion of differentiation-specific genes might be attenuated, but still
weakly active and rapidly switched to a more active state upon
activation of respective signaling cascades, initiating and accom-
panying the transition into another differentiation state. In this
scenario, the regulation of transcriptional activity might be exerted
by transcription factors acting in concert with signaling pathways.
For instance, a transient inflammatory signaling cascade activated
by Src kinase in human MCF10A cells triggers a Lin28B/let-7
mediated epigenetic switch resulting in engagement of transcrip-
tion factor STAT3 and acquirement of fully transformed
phenotype and CSC properties [78].
In a recent study related to our work, an identical epigenetic
state in the promoter region of the CD24 gene has been observed
between interconvertible CD24-positive and negative subsets of
CD44
+ breast cancer cells [50], indicating that transcriptional
permissiveness is a general phenomenon. It remains to be
elucidated how the specific set of transcription factors in G-2 cells
regulates the differentiation states and how the signaling cascades
are crossed with the activity of transcription factors.
Conclusion
The main challenge in tumor therapy remains to eradicate all
cancer cells. Thus the efficiency of a treatment strategy not only
depends on the understanding of the genetics and epigenetics of
single cancer cell or of distinct cellular subsets which might behave
like CSCs, but also on the knowledge of the mechanisms which
determine the behavior of the entire cancer cell population as a
dynamic, self-reproducing system.
Materials and Methods
Ethics statement
All mice were housed under SPF conditions in accordance with
official regulations for care and use of laboratory animals
(UKCCCR Guidelines for the Welfare of Animals in Experimen-
tal Neoplasia) and approved by Hamburg’s Authority for Health
(Nr. 88/06).
Establishment and propagation of G-2 cell culture
Singularized primary tumor cells were transferred into culture
according to a procedure published for normal mammary
epithelial cells [79]. All attempts to isolate a stable, SV40-LT
expressing epithelial cell line from WAP-T mice derived tumors
were unsuccessful, as during first days in culture the cells
progressively lost WAP-promoter dependent SV40-LT expression
and acquired a fibroblastic phenotype, as also described by others
[80]. However, we succeeded in establishing an epithelial cell
culture (termed G-2 cells) from a tumor of a WAP-TxWAP-
mutp53 bi-transgenic mouse [16,18]. Primary cells were propa-
gated in DMEM/10% FCS medium supplemented with 5 mg/ml
insulin, 5 mg/ml hydrocortisone, 5 mg/ml prolactin, and 5 mg/ml
b-estradiol (all from Sigma) at 37uC, 5% CO2. Starting from the
10th passage the cells were cultured in DMEM/10% FCS
medium without hormones and split twice per week at a 1:3 ratio.
Agar cloning
Seeding and culture of cells in soft agar was performed
according to standard procedures. After 2–3 weeks in the
incubator, colonies were counted, and single colonies were
transferred into 24-well cell culture dishes using sterile pipette
tips. Ten colonies from two independent experiments, C5, C9,
C10, C11, C13, K1, K2, K6, K7, and K8, were expanded into
stable cell lines.
siRNA transfection
Sox10 siRNA (XM_128139si.2; sense strand: 59-AAGGAC-
CAUCCGGACUACA-39) and control siRNA (sense strand: 59-
CGAACUUUUGGACGCGCAC-39) were obtained from Euro-
fins MWG Operon. siRNA transfections were performed in 6-well
cell culture plates using Oligofectamine
TM (Invitrogen) according
to manufacturer’s protocol.
Orthotopic transplantation
a) Preparation of primary cells. Tumor pieces were
minced with the help of 2 scalpels under sterile conditions,
washed with Quantum 286 medium (PAA) and treated with
enzymes (200 U/ml collagenase III (Worthington) and 100 U/ml
hyaluronidase type I-S (Sigma) in Quantum 286 medium) for 2–
4 h at 37uC under shaking. After washing with phosphate-buffered
saline (PBS) buffer, the cells were first treated for 5 min with
0.25% Trypsin-EDTA (Biochrom) at 37uC, followed by 15 min
treatment with dispase/DNaseI solution (20 U/ml dispase
(Worthington) and 100 U/ml DNase I (Sigma) in Quantum 286
medium) at 37uC. Cells were then resuspended in 5 ml MACS-
buffer (0.5 % BSA, 2 mM EDTA in PBS, pH 7.2) and sequentially
filtrated through a coffee mesh, 80 mm and 30 mm nylon filters
(Reichelt). After counting, the cell concentration was adjusted for
lineage depletion according to the manufacturer’s protocols
(lineage depletion kit, Miltenyi). Cell viability was assessed by
Trypan blue staining (Invitrogen).
b) Transplantation. Primary tumor cells or G-2 cells,
respectively, were resuspended in 20 ml of a 1:1 mixture of
Quantum 286 medium and BD Matrigel Matrix High
Concentration (HC), Growth Factor Reduced (GFR) (BD
Bioscience; Cat. No. 354263) and kept on ice until
transplantation. 8 to 16 weeks old virgin WAP-T-NP8 mice were
anesthetized by intra-peritoneal injection of 7–8 ml ketamine/
xylazine per gram (12 mg/ml ketamine, 1.6 mg xylazine in 0.9%
NaClsolution)and1.2 mlcarprofen pergram(50 mg/mlcarprofen,
Pfizer) was subcutanousely injected as analgesic. After a 1–2 mm
incision of the skin, the cell suspensions were injected with a 0.3 ml
Micro-Fine syringe (BD Bioscience, Cat. No. 4144150) into the left
abdominal mammary gland and the wound was sutured. The
operation was performed under sterile conditions. Size of growing
tumors was measured twice a week with a caliper.
Histology
Tissue specimens were fixed at room temperature overnight with
4% formaldehyde in 0.1 M phosphate buffer solution (pH 7.3),
washed for 4–6 hours in 0.1 M phosphate buffer and stored
thereafter in a 50% EtOH solution at 4uC. Fixed tissue specimens
were embedded in Paraplast X-TRA (Sherwood Medical) and
deparaffinized sections were stained with hematoxilin and eosin.
Digital pictures were taken with a Zeiss Axioskop 2 combined to a
CCD microscope camera ‘‘ProgRes C12’’ (Jenoptik).
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a) Tumor cryosections. Pieces of tumor tissues were
embedded in Shandon cryomatrix
TM (Thermo Scientific)
immediately after dissection, frozen on a mix of dry ice/isopentan
andconserved at280uC.7–8 mmcr yo se ct io nsw er ema d eat220uC
in a Leica CM3050 cryostat, collected on SuperFrost slides (Thermo
Scientific) and immunostained (the list of primary antibodies is in
Table S2). Secondary antibodies were purchased as AlexaH Dye or
DyLightH conjugates from Invitrogen and Dianova.
b) Adherently growing cells. 1610
5 cells were plated on
glass coverslips in 6-well plates, fixed with 4% paraformaldehyde
(PFA) in PBS, and immunostained (the list of primary antibodies is
in Table S2). Secondary fluorochrome-coupled antibodies were
obtained from Invitrogen.
Nuclei were stained either with DRAQ5 (Biostatus), DAPI
(Sigma) or TO-PROH-3 iodide (Invitrogen) and mounted with
Mowiol 4–88 (Merck). Images were captured as Z-stacks using an
Axiovert 200 microscope equipped with a LSM 510 META
confocal scanner (Carl Zeiss MicroImaging GmbH). Raw data
were exported to the Huygens Essential software (version 2.7.2p0,
Scientific Volume Imaging B.V.) and deconvoluted. The restored
image data sets were visualized and processed with the Imaris
software package (version 4.1.3, Bitplane AG). Colocalization was
calculated with the ImarisColoc module, and a map of the
colocalized voxels was saved as separate channel.
Flow cytometric analysis and fluorescence activated cell
sorting
Flow cytometric analyses were performed on FACScanto (BD
Bioscience) and fluorescence activated cell sorting (FACS) on a
FACSaria (BD Bioscience). Gating parameters were established
using negative controls. In the case of multiparameter analysis
single stained samples were used to establish gating parameters.
a) Antibody-staining of cell surface markers. Primary or
cultured cells were washed twice with MACS-buffer and
resuspended at a concentration of 1610
6 cells per 100 mli n
MACS-Buffer. Cells were labeled using the fluorescent dye
conjugated antibodies (the list of antibodies is in Table S2). After
30–45 min incubation on ice, the cells were washed twice with
MACS-buffer and resuspended at 1610
6 cells per 0.5 ml MACS-
buffer and transferred into a 4 ml tube.
b) Intracellular staining. 1610
6 cells were washed twice
with PBS and fixed with 500 ml 80% EtOH for 10 min, washed
twice with cold PBS/2 mM EDTA and permeabilized using
100 ml 1% Triton-X100 in PBS. After blocking with 500 ml 0.5%
BSA/PBS for 30 min, cells were incubated with primary (anti-
vimentin, Santa-Cruz; anti-keratin K18, Progen Biotechnik) and
Alexa488-, Alexa633-conjugated secondary antibodies (Invitrogen)
in 100 ml 0.5% BSA/PBS for 30 min, washed twice with 0.1%
Tween-20 in PBS/2 mM EDTA and resuspended in PBS/2 mM
EDTA for flow cytometry analysis. To define gates, Fluorescence
Minus One (FMO) controls were used and background
fluorescence was excluded using secondary antibodies alone.
c) Cytospin preparations. 5610
4 FACS-sorted cells were
diluted in 300 ml PBS. Slides and filters were placed into
appropriate slots in the cytospin (Cytospin 3; Shandon), with the
cardboard filters facing the center of the cytospin. Cells were spun
down at 500 rpm for 5 minutes. Filters were removed and slides
were dried for a few minutes. Immunofluorescent staining was
performed as described above.
d) DiI staining. Cells of the FACS-sorted CD24a
low/
CD49f
low subset were incubated with 2 mM DiIC18(5)-DS
(Invitrogen) in PBS for 5 min at 37uC while shaking, and then
for an additional 15 min at 4uC. The DiIC18(5)-DS labeling
efficiency was close to 99%. After labeling, cells were washed twice
with PBS, transferred into warm DMEM/10% FCS in 6-well
plates and either cultured alone or co-cultured at the 1:1 ratio with
non-labeled cells of the CD24a
high subset.
e) AldefluorH assay. To measure aldehyde dehydrogenase
activity, the AldefluorH kit (Stemcell technologies) was used
following the recommendations of the manufacturer. Briefly, the
cells were resuspended at 1610
6 cells per ml AldefluorH buffer and
5 ml of activated ALDH substrate per 1610
6 cells were added. As
negative control, 1 ml of the sample was treated with 5 mlo f
1.5 mM DEAB (diethylaminobenzaldehyde), a specific ALDH
inhibitor. The cell suspensions were rocked at 37uC for 40 min,
washed with AldefluorH buffer and finally resuspended in 0.5 ml
buffer.
Gene expression analysis
Total RNA was isolated from cells using TRIzolH (Invitrogen)
and digested with RNase-free DNase I (Qiagen) according to the
manufacturer’s instructions. The quality and integrity of the total
RNA was evaluated with the 2100 Bioanalyzer (Agilent Technol-
ogies). Labeling, hybridization on the Affymetrix microarray chips
(MOE430 2.0) and image data processing were completed by the
Signature Diagnostics AG (Potsdam) according to the Affymetrix
standard protocol. The raw signals were background corrected
and normalized using RMA procedure and quantile normalization
(Bioconductor package simpleaffy version 1.16.0) on the R
statistical platform (version 2.6.2). The differentially expressed
genes were identified using a Welch approximation based t-test
(package stats, version 2.6.2) followed by a Benjamini-Hochberg
correction procedure. Hierarchical clustering of genes and samples
was done using heatmap.2 procedure (package gplots, version
2.6.0), correlation distance with centroid linkage and visualized
using TreeView-ver.1.60 software. The microarray gene expres-
sion data discussed in this paper have been deposited in
MIAMExpress (http://www.ebi.ac.uk/microarray) and are acces-
sible through E-MEXP-2669 accession number.
Quantitative Real Time PCR
RNA was purified using the RNeasy Mini or Plus Micro Kits
(Qiagen), and reverse transcribed with the High Capacity RT kit
(Applied Biosystems). PCR was performed using the Power SYBR
Green PCR Mastermix (Applied Biosystems) in a standard
program running in an ABI 7500 Fast thermal cycler (Applied
Biosystems). PCR reactions for each sample were repeated in
triplicates. The integrity of the amplified products was confirmed
by melting-curve analysis. PCR primers (see Table S2 for primer
sequences) were selected from a Primer Bank (http://pga.mgh.
harvard.edu/primerbank/index.html) or designed using Primer
Designer 4 (Scientific & Educational Software). PCR efficiency
was measured for each primer pair using serial dilution of cDNA.
Gapdh was used as endogenous control. Relative quantitation of
transcript levels with respect to the calibrator was done based on
2
2DDC
T algorithm.
Lentiviral transduction
The SFFV-promoter in the LeGo-G lentiviral, eGFP-coding
vector (kindly provided by Dr. Carol Stocking) was replaced by a
sequence upstream of the Wap gene. Briefly, a 1,454 bp fragment
of an upstream sequence flanking the Wap transcription start site
was amplified by nested PCR (see for primer sequences in Table
S2) from mouse genomic DNA and inserted into the BamHI/NotI
cloning sites of the LeGo-G vector. 293T packaging cells were
grown to around 50% confluence on a 10-cm dish. For virus
production, third-generation packaging plasmids pMDLg/pRRE
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Carol Stocking, HPI) were mixed for co-transfection with 4 mg
LeGo-G plasmid DNA and PEI transfection reagent (Polysciences)
in 1 ml Optimem (Invitrogen) medium and incubated for 10 min.
The medium of 293T cells was replaced by 5 ml Optimem
containing the transfection mixture and cells were incubated 12 h
at 37uC. The medium was exchanged with 5 ml DMEM/10%
FCS and transfected cells were incubated for further 2 days. Cell
culture medium containing viral particles was harvested, cleared
through a sterile filter (pore size 0.45 mm), and stored at 280uC.
For lentiviral transduction, G-2 cells were grown to around 50%
confluence on 6-well plates. 3 days after transduction, eGFP
expression was analyzed by live-cell fluorescence imaging in a
Leica DMI6000 B microscope. eGFP-expressing cells were
enriched by cell sorting.
Supporting Information
Table S1 Excel datasheets containing data of gene expression
microarray analysis and list of genes used for generation of heat
maps.
Found at: doi:10.1371/journal.pone.0012103.s001 (6.84 MB
XLS)
Table S2 List of primers and primary antibodies used in this
study.
Found at: doi:10.1371/journal.pone.0012103.s002 (0.03 MB
XLS)
Figure S1 Expression of intermediate filament proteins in cells
of G-2 subclones. (A, B) Confocal images of cells of G-2 clones C9
(A) and C11 (B) stained with antibodies against keratin 14 (green)
and keratin 18 (red). Nuclei were visualized with TO-PRO-3.
Confocal sections were deconvoluted using Huygens Essential and
processed with Imaris software. (C, D) 5 clones of the first G-2
cloning (C5, C9, C10, C11, and C13: late passages [P.10]) and 5
of the second cloning (K1, K2, K6, K7, and K8: early passages
[P,3]) were subjected to real-time qPCR analysis for Krt14 (C)
and Krt18 (D) expression. Gapdh was used as housekeeping gene
and the respective results were calibrated on parental G-2 cell
expression values. (E, F). 7 and 6 secondary clones, respectively,
derived from primary clones G-2C9 (E: sC9-1, sC9-2, sC9-3, sC9-
5, sC9-6, sC9-7 and sC9-8) and G-2C11 (F: sC11-2, sC11-3, sC11-
4, sC11-6, sC11-7, and sC11-8) were subjected to real-time qPCR
analysis for SV40-LT, Krt14 and Krt18 expression. Gapdh was
used as housekeeping gene and the respective results were
calibrated on sC9-1 and sC11-2 expression values. (G) Confocal
images of G-2 cells and subclones G-2C5, G-2C9, G-2C10 and G-
2C13 stained for vimentin (green). Nuclei were visualized with
TO-PRO-3. Confocal sections were deconvoluted using Huygens
Essential and processed with Imaris software. Scale bar: A and B:
20 mm; G: 30 mm.
Found at: doi:10.1371/journal.pone.0012103.s003 (2.15 MB TIF)
Figure S2 Characterization of transplanted G-2 tumor in
BALB/c wild-type recipient mouse. (A–D) Immunostaining of a
G-2 tumor in BALB/c recipient mouse for (A) Epcam (red), (B)
keratin 8/18 (red) and vimentin (green), (C) SV40-LT (red) and
vimentin (green), and (D) keratin 14 (red). Residual structures of
the normal mammary gland were observed in A (positive for
Epcam), B (positive for keratin 8/18) and C (positive for keratin
14). Nuclei were visualized with DAPI. Scale bars: 200 mm.
Found at: doi:10.1371/journal.pone.0012103.s004 (4.05 MB TIF)
Figure S3 qPCR analysis of G-2 subsets. (A, B) FACS-sorted
CD49f
high/CD24a
high and CD49f
low/CD24a
low (A) or Sca1
high
and Sca1
low (B) G-2 subpopulations were subjected to real-time
qPCR analysis for SV40-LT, Krt14 and Krt18 expression. Gapdh
was used as housekeeping gene and the respective results were
calibrated on the expression values of CD49f
low/CD24a
low and
Sca1
low subpopulations. (C) Real-time amplification plots of
CD49f
high/CD24a
high and CD49f
low/CD24a
low samples for
Gapdh, Cd24a, Cd49f, and Sca1 shown on a logarithmic scale
Delta Rn.
Found at: doi:10.1371/journal.pone.0012103.s005 (0.87 MB
TIF)
Figure S4 Characterization of the Thy1
high cell population of G-
2 cells and subclones. (A) Representative FACS dot plots showing
the expression of Thy1 in 5 clones of the first G-2 cloning (C5, C9,
C10, C11, and C13: late passages [P.10]) and 2 of the second
cloning (K1 and K2: early passages [P,3]). The gating was
adjusted with the help of an antibody control. (B) Co-immuno-
staining of G-2 cells grown on coverslips for Sca1 (red) and Thy1
(green). Nuclei were stained with DAPI. (C) Thy1
low and Thy1
high
G-2 subsets were FACS sorted and transcription levels of Cd24a
and Cd49f genes were analyzed via real-time qPCR. Gapdh was
used as housekeeping gene and results were calibrated on the
expression values of the Thy1
low subpopulation. (D) Cytospin
preparations of FACS-sorted Thy1
high and Thy1
low G-2C9 cells
were stained for keratin 18 (D, upper panels) and vimentin (D,
lower panels). Nuclei were stained with DAPI. Scale bar: C:
40 mm; D: 75 mm.
Found at: doi:10.1371/journal.pone.0012103.s006 (2.37 MB TIF)
Figure S5 Repopulation activity of G-2K1 and G-2K2 cell
subsets. Representative FACS dot plots showing the repopulation
activity of two G-2 clones, G-2K1 (upper row) and G-2K2 (lower
row), differing in the expression of CD24a and CD49f.
CD24a
high/CD49f
high and CD24a
low/CD49f
low subsets were
gated during cell sorting to exclude any overlap. 5610
4 sorted
cells were transferred back into culture and the composition of the
culture was analyzed 3 and 5 days later by FACS.
Found at: doi:10.1371/journal.pone.0012103.s007 (1.04 MB TIF)
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